Hence, LRBA deficiency usually results in immune dysregulation and autoimmunity in CVID patients. LRBA mutations were also associated with inflammatory bowel disease-like disorder, and immune dysregulation, polyendocrinopathy, enteropathy, and X-linked-like disease [28, 29]. Here, LRBA is linked to polyendocrinopathy.